/

CSBR

Champions Oncology, Inc.Pre-market

4.90−0.05 −1.08%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delay

Open

4.87

Prev close

4.95

Day range

4.814.93

52-week range

4.598.31

Volume

3.07K0.28×

Mkt cap

68.20M

P/E ttm

—

Fwd P/E

49.00

EPS ttm

-0.0700

Div yield

0.00%

Earnings

Sep 10, 2026

From 52w high

−41.03%

Price Chart

Yahoo Finance · delayed

CSBROct 13, 2026O 4.81H 4.93L 4.72C 4.90−0.05 (−1.01%)Vol 3.10K

SMA 505.04
SMA 2005.88

1Y change −24.73% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

CSBR Champions Oncology, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −2.20%
1 month: −3.92%
3 months: −13.43%
6 months: −14.49%
Year to date: −29.09%
1 year: −24.73%

Valuation & ownership

Market cap: 68.20M
Enterprise value: 75.38M
P/E (ttm): —
Forward P/E: 49.00
PEG ratio: —
Price / book: 17.50
Price / sales (ttm): 1.12
EV / EBITDA: 187.51
EPS (ttm): -0.0700
EPS (forward): 0.1000
Beta (5y monthly): 0.44
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 13.92M
Float: 6.11M
Short % of float: 1.04%
Short ratio (days): 4.95
Held by insiders: 26.33%
Held by institutions: 48.71%
Avg volume (3m): 11.12K
50-day average: 5.05
200-day average: 5.89
52-week change: −24.73%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 46.3
vs 50-day SMA: −2.70%
vs 200-day SMA: −16.63%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 4.51%
Realised vol (20d, ann.): 41.5%
From 52-week high: −41.03%
From 52-week low: +6.75%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): 60.66M
Revenue growth (yoy): +8.80%
Earnings growth (yoy): —
Gross margin: 49.82%
Operating margin: -2.69%
Profit margin: -1.87%

DES

About Champions Oncology, Inc.

Yahoo Finance profile

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Sector: Healthcare
Industry: Biotechnology
Employees: 214
Headquarters: Hackensack, NJ, United States
Website: championsoncology.com
Officers: Dr. Ronnie Morris M.D. Executive Chair
Mr. Robert Brainin CEO & Director
Mr. David Barry Miller M.B.A. Chief Financial Officer

SEAS

Seasonality · CSBR

2007–2026 · monthly returns

Strongest month Dec +12.83%Weakest month Jul −3.39%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	5.8	-18.5	-3.5	3.7	-2.0	5.5	-13.0	-6.7	0.0	-2.0			−29.1%
2025	28.2	-6.5	-15.6	-17.6	-17.9	25.6	-14.2	7.6	-4.7	5.6	-4.4	5.7	−19.4%
2024	3.4	1.5	-16.9	-1.0	-6.6	14.1	-7.4	-11.9	15.4	-19.7	15.6	89.6	+52.5%
2023	-8.9	13.1	-13.5	22.4	5.9	22.5	1.9	3.1	-7.3	-12.1	-5.7	9.1	+24.6%
2022	-4.1	-2.1	3.6	-5.5	-3.6	8.1	8.2	-7.9	-6.0	-7.5	-0.6	-34.6	−46.1%
2021	1.8	6.4	-3.3	-5.0	-12.3	9.2	1.7	-7.3	5.4	-4.3	-18.9	5.6	−22.5%
2020	-8.9	-17.0	17.5	4.3	24.7	-0.7	-8.6	-5.3	11.7	-5.1	29.5	-5.1	+29.5%
2019	56.6	-5.0	-15.7	-7.3	3.1	-16.3	-17.4	-16.5	4.6	-7.4	10.1	44.6	+6.7%
2018	-1.5	-9.2	4.9	19.2	6.7	36.9	26.2	10.2	98.1	-29.1	2.3	-38.4	+101.3%
2017	87.7	-27.4	-8.1	-16.4	-9.1	6.6	10.5	6.7	21.1	-12.8	12.2	8.1	+53.4%
2016	1.4	0.8	-0.3	5.8	-14.0	-35.0	-8.8	-18.9	5.7	-6.0	39.2	15.0	−29.1%
2015	-10.0	-28.9	118.7	-12.9	-9.8	-9.1	-4.0	9.2	-14.9	2.1	-16.7	-21.5	−40.5%
2014	-16.7	18.0	-16.1	-8.1	4.4	5.3	-11.0	-12.4	-5.1	-5.4	-8.6	-21.9	−58.3%
2013	70.0	11.8	5.3	-16.7	-6.0	134.0	-3.6	22.6	34.6	-26.3	-22.5	20.0	+300.0%
2012	-6.7	5.7	-12.2	3.1	-7.5	-27.4	-8.9	-14.6	0.0	28.6	6.7	-37.5	−60.0%
2011	-1.1	1.1	-6.7	19.0	20.0	-20.8	-10.5	-5.9	10.0	-14.8	-1.3	1.4	−16.7%
2010	0.0	12.5	8.9	-13.3	8.2	0.0	3.3	-15.8	6.2	11.8	-5.3	0.0	+12.5%
2009	-3.7	5.8	-4.5	-4.8	5.0	-24.8	-1.3	-1.3	-9.1	14.3	0.0	0.0	−25.9%
2008	-35.0	48.4	-14.8	11.3	-14.1	-13.6	-24.2	38.9	0.0	-56.0	-18.2	200.0	−22.9%
2007			2.9	-16.7	123.3	-20.9	3.8	0.0	12.7	174.2	-20.6	3.7	+300.0%

INSD

Insider Activity · CSBR

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Oct 29, 2025	Ackerman JoelDirector	Conversion of Exercise of derivative security at price 2.10 per share.	94.4K	$198.25K
Oct 30, 2024	Ackerman JoelDirector	Conversion of Exercise of derivative security at price 2.10 - 5.43 per share.	105.1K	$276.29K

13F

Investors Holding CSBR

latest 13F filings of 29 followed managers

Investors holding CSBR
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$856.5K	0.00%	139.04K	−4.5%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

CSBR

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

CSBR

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Champions Oncology, Inc.

Seasonality · CSBR

Insider Activity · CSBR

Congress Trades · CSBR

Investors Holding CSBR

Investors Holding CSBR

Congress Trades · CSBR

Insider Activity · CSBR

Seasonality · CSBR

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Champions Oncology, Inc.

Earnings & Dividends

News